🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Combined Hepatocellular-cholangiocarcinoma

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors NCT06487663NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: TACE with ICI Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data NCT06849180n/a1 site📍 Nanjing Zhongda Hospital · Tests: Interventional therapies combined with or without systemic drugs HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA) NCT07105748Phase 21 site📍 Shanghai Fudan University · Tests: Camrelizumab, Rivoceranib (Apatinib), HAIC Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) NCT05451043Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Durvalumab, Gemcitabine, Nab paclitaxel, Tremelimumab, Propranolol The Dragon PLC Trial (DRAGON-PLC) NCT06914648NA55 sites📍 New Haven📍 Chicago📍 Rochester Maastricht University · Tests: Portal Vein Embolization, Hepatic Vein Embolization DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection. NCT07717437n/a31 sites📍 Chicago📍 Rochester📍 Cleveland Maastricht University Medical Center
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy